Nikolaos Trikalinos
Washington University in St. Louis
H-index: 13
North America-United States
Top articles of Nikolaos Trikalinos
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Race and Odds of Surgery Offer in Small Bowel and Pancreas Neuroendocrine Neoplasms. | Annals of Surgical Oncology | Zarate Rodriguez JG L Raper DE Sanford NA Trikalinos CW Hammill | 2024/1/31 |
Predictors of high-intensity care at the end of life among older adults with solid tumors: A population-based study | Journal of Geriatric Oncology | Courtney E Baird Elizabeth Wulff-Burchfield Pamela C Egan Lee A Hugar Ami Vyas | 2024/6/1 |
Use of approved Lu‐177 radiopharmaceuticals in patients with end‐stage renal disease: A review of the literature and proposed treatment algorithm | Nikolaos A Trikalinos Hyun Kim Anitha Vijayan Maxwell Amurao Vikas Prasad | 2024/4/15 | |
Abstract CT130: Epacadostat with preoperative chemoradiation in locally advanced rectal cancer (LARC): Results of a translational phase I clinical trial | Cancer Research | Haeseong Park Katrina Pedersen Katherine Huang Matthew Mutch Hyun Kim | 2024/4/5 |
Treatment of metastatic rectal squamous cell carcinoma in a pregnant patient | BMJ Case Reports CP | Nathan S Kau Jeannie C Kelly Hyun Kim Radhika Smith Tyler J Fraum | 2024/2/1 |
A pilot study of liposomal irinotecan plus 5-FU/LV combined with paricalcitol in patients with advanced pancreatic cancer whose disease progressed on gemcitabine-based therapy. | Patrick Grierson Rama Suresh Benjamin R Tan Katrina Sophia Pedersen Manik A Amin | 2023/6/1 | |
Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701) | Kathryn J Ruddy David Zahrieh Jun He Blake Waechter Julianne L Holleran | 2023/2/1 | |
Phase Ib study of ulixertinib plus gemcitabine and nab-paclitaxel in patients with metastatic pancreatic adenocarcinoma | The Oncologist | Patrick M Grierson Benjamin Tan Katrina S Pedersen Haeseong Park Rama Suresh | 2023/2/1 |
STK11 alterations as predictive biomarkers of resistance to immune checkpoint inhibitors in multiple cancers with mismatch repair gene alterations. | Michael Iglesia Moh'd M Khushman Kian-Huat Lim Brian Andrew Van Tine Jingxia Liu | 2023/6/1 | |
A pilot study of paricalcitol plus nanoliposomal irinotecan and 5-FU/LV in advanced pancreatic cancer patients after progression on gemcitabine-based therapy | Clinical Cancer Research | Patrick M Grierson Rama Suresh Benjamin Tan Katrina S Pedersen Manik Amin | 2023/12/1 |
A phase 2 study of the WEE1 inhibitor AZD1775 in SETD2-deficient advanced solid tumor malignancies. | Edward Maldonado Wendy Kimryn Rathmell Geoffrey Shapiro Jordi Rodon Ahnert Devalingam Mahalingam | 2023/6/1 | |
Correction: Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: a Phase I Dose Escalation and Expansion Study | Clinical Cancer Research | Andrea Wang-Gillam Kian-Huat Lim Robert McWilliams Rama Suresh Albert C Lockhart | 2023/11/14 |
Therapy Sequencing in Patients With Advanced Neuroendocrine Neoplasms | American Society of Clinical Oncology Educational Book | Rachel P Riechelmann Rodrigo G Taboada Victor Hugo F de Jesus Michael Iglesia Nikolaos A Trikalinos | 2023/5 |
LBA53 Alliance A021602: Phase III, double-blinded study of cabozantinib versus placebo for advanced neuroendocrine tumors (NET) after progression on prior therapy (CABINET) | Annals of Oncology | J Chan S Geyer FS Ou M Knopp S Behr | 2023/10/1 |
Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations | Virchows Archiv | Pooja Navale Deyali Chatterjee Malak Itani Nikolaos A Trikalinos | 2023/8 |
Pancreatic neuroendocrine tumors: tailoring imaging to specific clinical scenarios | Katerina S Konstantinoff Ajaykumar C Morani Thomas A Hope Priya R Bhosale Isaac R Francis | 2023/5 | |
Phase I dose escalation and expansion study of defactinib, pembrolizumab, and gemcitabine in patients with advanced treatment-refractory pancreatic cancer. | Andrea wang-gillam Kian-Huat Lim Robert R McWilliams Rama Suresh A Craig Lockhart | 2022/6/1 | |
Enterochromaffin-like cell hyperplasia–associated gastric neuroendocrine tumors may arise in the setting of proton pump inhibitor use: the need for a new clinicopathologic category | Archives of Pathology & Laboratory Medicine | Rehan Rais Nikolaos A Trikalinos Jingxia Liu Deyali Chatterjee | 2022/3/1 |
Supportive interventions for childhood cancer: An umbrella review of randomized evidence | Georgios Lavasidis Georgios Markozannes Kirsten Voorhies Nikolaos A Trikalinos Eleni Th Petridou | 2022/12/1 | |
Inflammatory bowel disease and coexistence of neuroendocrine neoplasms: A review of the literature. | Imad Karam Nikolaos Trikalinos | 2022/6/1 |
Co-Authors
